Delivery Order SPE2DB20D9766-SPE2DB25FC1GC
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for BOTOX 200 Unit Vials valued at $12,937.00 by the Defense Logistics Agency (DLA) on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's Park Ridge facility. The award is issued under the company's existing...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,850.28 by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Botox 100-unit vials. The contract, which carries no set-aside designation, is scheduled for completion by September 10, 2025, with performance taking place at the awardee's Park Ridge, Illinois facility. This delivery order is issued...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,700.56 by the Defense Logistics Agency (DLA) for the supply of Botox 100 unit vials. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of September 5, 2025, was issued without a set-aside designation. The contract is performed at the contractor's facility in Park Ridge, Illinois, and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The contract, executed on August 8, 2025, with an ultimate completion date of August 29, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,587.40 by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Botox 200 Unit Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 5, 2025, and was awarded without any set-aside designation. Performance will take place at the vendor's Park Ridge, Illinois location....
- The Defense Logistics Agency awarded a delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, represents a single-award transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48.6K on July 22, 2025, for the supply of Botox 100 Unit Vials. The contract utilizes a firm fixed-price delivery model with an ultimate completion date of August 12, 2025, and was funded by the Defense Logistics Agency's Medical Supply Chain division. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,293.72 by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Botox 200 unit vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and does not utilize a set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for BOTOX 200 unit vials valued at $7.76K by the Defense Logistics Agency (DLA) on August 18, 2025, with an ultimate completion date of September 9, 2025. The contract utilizes firm fixed-price pricing and does not employ a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,938.55 by the Defense Logistics Agency on August 19, 2025, for the supply of Botox 100 Unit Vials. The contract, which carries an ultimate completion date of September 10, 2025, was issued without set-aside designation. This delivery order represents one of many pharmaceutical supply contracts DMS Pharmaceutical Group...
- SPE2DB20D9766Indefinite Delivery Contract
- SPE2DB20D9766-SPE2DB25FC1GCDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19.4K by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Botox 200 unit vials. The delivery order carries an ultimate completion date of September 16, 2025, and represents a non-set-aside competitive award. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at $500M through November 2026, which authorizes the agency to issue firm fixed-price orders for comprehensive pharmaceutical products supporting military health facility operations worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to secure contracts across the DLA's pharmaceutical distribution network. The company specializes in delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites, with its contract portfolio demonstrating consistent expertise in supplying specialty pharmaceuticals including injectables, oncology treatments, and medical devices. This Botox delivery order exemplifies the company's role in supporting the medical supply needs of military healthcare facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.4k | 8/25/25 |